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Introduction
Nalbuphine (NAL) (m)-17-(cyclobutylmethyl)-4,5a-poxymorphinan-3,6a,14-triol ( Fig. 1) is semi synthetic narcotic agonist-antagonist of the phenanthrene series. Structurally, it is closely related to naloxone, an antagonist of the opiate receptors and to oxymorphone, a narcotic agonist. Nalbuphine has been shown to be approximately equianalgesic to morphine, yet with a ceiling effect on ventilator depression and fewer adverse effects than pethidine or pentazocine. As an analgesic agent, it is almost as potent as morphine and has been widely used in the treatment of acute and chronic pain [1] .
Its main advantages over morphine are a ceiling effect of respiratory depression, low tolerance liability and a lack of significant withdrawal symptoms. It is available as an injection for intramuscular and intravenous administration. The usual recommended doses are 10-20 mg by intravenous or intramuscular injection every 3-4 h. A few methods have been described to detectNalbuphine in pharmaceutical formulations and in biological fluids such as; gas chromatography coupled to electroncapture detection [2] , mass spectrometry [3] , high-performance liquid chromatography with electrochemical detection [4] and LC-MS/MS [5] . However, most of the above methods require several time consuming manipulation steps, sophisticated instruments and special training. Hence, it is of primary importance to develop an alternative method for determination of NAL with a high degree of selectivity and sensitivity. Luminescent photo probes lanthanide complexes have more advantages over the present ones; photo probe has high stability and durability. The photo probe can provide constant signal response for 2 years which is 24-fold better stability compared to the life time warranted for the chromatographic and colorimetric methods [6] [7] [8] [9] [10] [11] [12] [13] [14] . Photo probe is stable over all measurements which prevent the source of error in the measurement process and it gives a low standard deviation values. In this work, NAL was determined by using photo probe [Tb
3+
-CCE] in DMF at pH 6.5 and λ ex = 285 nm.
Experimental

Materials
Pure standard Nalbuphine HCl supplied by the National Organization for Drug control and Research (Giza, Egypt). Pharmaceutical preparation of Nalufin injection containing 20 mg/mL produced by Amoun Pharmaceutical Company, Egypt.
Reagents
All chemicals used are of analytical grade and pure solvents were purchased from Aldrich. 
Apparatus
All luminescence measurements were recorded with a Meslo-PN (222-263000)z Thermo Scientific Lumina fluorescence Spectrometer in the range (190 -900 nm). The absorption of the samples was measured in the range of 220 -750 nm with Thremo UV-Visible double-beam spectrophotometer. The pH was measured using with a pHs-janway 3330 research pH meter. The separation of protein from samples was carried out by centrifuging of sample for 15 min and 3000 rpm.
General procedure
To 10 mL measuring flasks, solutions were added in the following order: 0. 4'carboxybenzo-18crown-6-ether solution. The above procedure was used for the subsequent measurements of absorption, emission spectra and pH and solvent effects. The luminescence intensity was measured at λex/λem =285/545nm.
Determination ofNalbuphine in serum solution 3 mL of trichloroacetic acid was added to 1.0 mL serum of a real health volunteers and the solution was centrifuged for 15 min at 4000 r/min to remove proteins, then 100 µL of the serum was added to 0.1 mL of Tb -4'carboxybenzo-18crown-6-ether on stock solution (1.0 x 10 -2 mol L -1 ) in 10 mL measuring flask and complete to the mark with DMF and. The luminescence intensity of the test solution was measured before and after addition of Tb -4'carboxybenzo-18crown-6-ether photo probe. The change in the luminescence intensity was used for determination of (NAL) in serum sample.
Result and Discussion
Absorption Spectra
The absorption spectrum of (4'carboxybenzo18crown-6-ether) shows (Fig. 2 ) a band at 284 nm due to the π→ π * transition in the CCE. Upon addition of Tb 3+ to CCE in DMF, a red shift by 8 nm was observed and the absorbance is also enhanced which indicates that CCE can form a complex with Tb 3+ ion.
Effect of the Experimental Reagents Effect of the amount of (4'carboxybenzo18crown-6-ether) and Tb
3+
The ion titration revealed that the complex formed M : L (1 : 1) for Tb and (4'carboxybenzo18crown-6-ether), which indicates that the metal .
Effect of pH
The pH of the medium has a great effect on the luminescence intensity of the Tb-(4'carboxybenzo-18crown-6-ether). The optimum pH is 6.5 at which the highest peak intensity at (Fig. 5) .
Also, the luminescence intensity for the complex in DMF solution is stronger than in ethanol as hydroxyl solvent. This may be due to vibrational energy transfer to the solvent molecules. It is well knowing that the excited state of the lanthanide ions is efficiently quenched by interactions with high-energy vibrations like O-H groups thereby the luminescence of this complex in -OH containing solvents can be quenched easily because of the O-H oscillators [15] [16] [17] [18] [19] [20] [21] [22] .
Emission spectra
The emission spectra of Tb 3+ -(4'carboxybenzo18crown-6-ether) complex in different concentrations of (NAL) are shown in Fig. 6 . After the addition of different concentrations of (NAL) into the Tb 3+ -4'carboxybenzo-18crown-6-ether ion in DMF, the intensity of the characteristic peak at 545 nm of Tb -4'carboxybenzo-18crown-6-ether was quenched indicating that (NAL) quenches the energy of the complex Tb [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] .
Analytical performance Analytical parameters of photo probe method
A linear correlation was found between luminescence intensity of Tb-CCE complex at λem = 545 nm and concentration of NAL in the ranges given in Table 1 Limit of quantification(LOQ),molL analysis of luminescence intensity data using the method of least squares was made to evaluate the slope (b), intercept (a) and correlation coefficient (r) and the values were presented in Table 1 . The limit of detection (LOD) and quantitation (LOQ) calculated according to ICH guidelines [41] using the formulae: LOD = 3.3 S/b and LOQ = 10 S/b, (where S is the standard deviation of blank luminescence intensity values, and b is the slope of the calibration plot) are also presented in Table 1 . The low value of LOD indicates the high sensitivity of the proposed method when compared by other methods [2] [3] [4] [5] .
Selectivity The proposed method was tested for selectivity by placebo blank and synthetic mixture analysis. A placebo blank containing talc (250 mg), starch (300 mg), lactose (30 mg), calcium carbonate (50 mg), calcium dihydrogen orthophosphate (20 mg), methyl cellulose (40 mg), sodium alginate (70 mg) and magnesium stearate (100 mg) was extracted with water and solution made as described under "analysis of dosage forms". A convenient aliquot of solution was subjected to analysis according to the recommended procedures. In the method of analysis, there was no interference by the inactive ingredients.
A separate test was performed by applying the proposed method to the determination of NAL in a synthetic mixture. To the placebo blank of similar composition, different amount of NAL of pharmaceutical formulation Nalufin was added, homogenized and the solution of the synthetic mixture was prepared as done under "analysis of dosage forms". 1.0, 2.0 and 4.0 mL of the resulting solution was assayed (n=9) by proposed method which yielded a % average recovery of 100.4 ± 1.13, and 98.6 ± 0.5 for injection and serum samples, respectively. The results demonstrated the accuracy as well as the precision of the proposed method.
Application to formulations
The proposed method was applied to the determination of NAL in one representative pharmaceutical formulation 20 mg Nalufin was purchased from Amoun Pharmaceutical Company and serum sample of the health state volunteer. The results in Table 2 show that the method is successful for the determination of NAL and that the excipients in the dosage forms did not interfere. The results obtained and given in Table  2 were statistically compared with the official British Pharmacopoeia [B.P] method [42] .
The average recovery and R.S.D for the injection and serum samples in proposed method were (100.4 ± 1.13, and 98.6 ± 0.5) respectively. Data obtained by B. P method average recovery 99.5% and 99.8 for the injection and serum samples respectively; and R.S.D was also presented for comparison and shows a good correlation with those obtained by the proposed method. The results obtained by the proposed method agreed well with those of reference method and with the label claim ( Table 2) . Accuracy was evaluated as percentage relative error (RE) between the measured mean concentrations and the taken concentrations of NAL. Bias {bias %= [(Concentration found -known concentration) x 100 / known concentration] was calculated at each concentration and these results are also presented in Table 2 . Percent relative error (% RE) values of ≤ 0.16-5.0 % (intra-day) and ≤ 1.22-6.89 % (inter-day) demonstrates the high accuracy of the proposed method.
Conclusion
The Tb 3+ ion in DMF has high sensitive and characteristic peaks in the presence of (carboxycrown-ether). The proposed method for the determination of (nalbuphine HCl) offers simple, rapid and sensitive method for the analysis of (nalbuphine HCl) in DMF and pH 6.0 with a linear range of 5x10 -8 to 1.2x10 -6 mol L -1 and detection limit of 9.4 x10 -9 mol L -1 . The developed photo probe is selective, accurate and attractive for routine control analysis of the drug.
